Company News in the Life Science Industry

»

Reset 

Sanofi: information concerning the total number of voting rights and shares, December 2019

Read more ››
By: GlobenewsWire - 17 Jan 2020

NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2019 Financial Results Conference Call

Read more ››
By: GlobenewsWire - 17 Jan 2020
Related companies:  NEUROMETRIX, INC.

AVRA Medical Robotics Attends J.P. Morgan Healthcare Conference

Read more ››
By: GlobenewsWire - 17 Jan 2020

Generex Biotechnology Provides Investor Conference Call Details Tuesday January 21, 2020 at 9:30 AM

Read more ››
By: GlobenewsWire - 17 Jan 2020
Related companies:  Generex Biotechnology Corp. | Genovior Biotech Corporation

TCS: Strong Share Gains in Europe Stand Out in Seasonally Weak Q3

MUMBAI, India, Jan. 17, 2020 /PRNewswire/ -- Tata Consultancy Services (BSE: 532540, NSE: TCS), the leading global IT services, consulting and business solutions organization, reported its consolidated financial results according to Ind AS and IFRS, for the quarter ending December 31, 2019.

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  Tecsys Inc.

Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, Jan. 17, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD) (the "Company"), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that it has entered into definitive agreements with certain... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  Aethlon Medical, Inc.

PANTHERx® Rare Pharmacy Selected by Blueprint Medicines Corporation to Distribute AYVAKIT(TM) (avapritinib) for Genomically Defined Patient Population with Rare Cancer, GIST

PITTSBURGH, Jan. 17, 2020 /PRNewswire/ -- PANTHERx(®) Rare Pharmacy announces that it has been selected by Blueprint Medicines Corporation as a very limited distribution partner for breakthrough drug AYVAKIT(TM) (avapritinib). It has been approved for the treatment of adult patients with unresectable... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  Blueprint Medicines Corporation

Biotech Sector's Technological Advancements Winning Major Battles in the War on Cancer

LOS ANGELES, Jan. 17, 2020 /PRNewswire/ -- USA News Group - In the war against cancer, it appears that all hands are on deck, with contributions coming from across the biotech sector.... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

Allianz Foundation for North America Provides $50,000 Grant to Cameron K. Gallagher Foundation

RICHMOND, Va., Jan. 17, 2020 /PRNewswire/ -- Allianz... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

Laura van 't Veer, PhD, Co-Inventor of MammaPrint, Honored with the PMWC Luminary Award at Precision Medicine World Conference 2020

IRVINE, Calif. and AMSTERDAM, Jan. 17, 2020 /PRNewswire/ -- Laura van 't Veer, Ph.D., co-founder of Agendia Inc. and developer of MammaPrint, the 70-gene risk of recurrence assay for breast cancer patients, will be recognized by Precision Medicine World Conference with the PMWC Luminary Award... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  Agendia Inc. USA

Hundreds of Future Urologists Celebrate Match Day

BALTIMORE, Jan. 17, 2020 /PRNewswire/ -- Earlier today, the Society of Academic Urologists (SAU) and the American Urological Association (AUA) announced the Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

The global fertility services market generated $13,655 million in 2018 and is projected to reach $27,151 million by 2026, growing at a CAGR of 8.9% from 2019 to 2026

NEW YORK, Jan. 17, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2020

Parkinson's Drug Market and Clinical Trial Insights Report, 2020-2025 - Availability, Dosage & Price Analysis on Levodopa/Carbidopa Therapeutics, Dopamine Agonist, MAO B Inhibitors, and More

DUBLIN, Jan. 17, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

The global tumor (cancer) profiling market at a CAGR of over 10% during the forecast period

NEW YORK, Jan. 17, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2020

Veterinary Healthcare Global Market Opportunities And Strategies To 2023

NEW YORK, Jan. 17, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 17 Jan 2020

6th Perinatal Stem Cell Society Congress | Salt Lake City, United States - March 4th-6th, 2020

DUBLIN, Jan. 17, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services

DURHAM, N.C., Jan. 17, 2020 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced it has acquired TriPharm Services ("TriPharm"), a new state-of-the-art sterile fill-finish... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  Alcami Corporation, Developmental Services | Alcami Corporation

AMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco

SAN FRANCISCO, Jan. 17, 2020 /PRNewswire/ -- AMPEL BioSolutions' Co-Founder and COO/CSO Dr. Amrie Grammer today at the Biotech Showcase at JP Morgan Healthcare announces the kickoff of a Series A $12.5M raise to commercialize LuGENE(TM), a gene-based diagnostic. AMPEL's initial focus is Lupus,... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

Global Transdermal Patch Industry Outlook and Forecast 2020-2026: Dosage & Price Insights, Clinical Trials by Company, Drug Class, Indication & Patent Information

DUBLIN, Jan. 17, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020

APSARD and Tris Pharma Announce the Inaugural Tris Research Award in ADHD

MONMOUTH JUNCTION, N.J., Jan. 17, 2020 /PRNewswire/ -- The American Professional Society of ADHD and Related Disorders (APSARD) is a U.S.-based international organization of health professionals and scientists focusing exclusively on ADHD and related disorders and Tris Pharma, Inc. ("Tris"),... Read more ››

By: PR Newswire Association LLC. - 17 Jan 2020
Related companies:  Tris Pharma, Inc.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies